Journal of Psychopharmacology
Published by SAGE
ISSN : 0269-8811 eISSN : 1461-7285
Abbreviation : J. Psychopharmacol.
Aims & Scope
The Journal of Psychopharmacology is a fully peer-reviewed, international journal that publishes original research and review articles on preclinical and clinical aspects of psychopharmacology.
The journal provides an essential forum for researchers and practicing clinicians on the effects of drugs on animal and human behavior, and the mechanisms underlying these effects.
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 5.5 |
2024 | 4.50 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 1.708 |
Quartile
Year | Value |
---|---|
2024 | Q1 |
h-index
Year | Value |
---|---|
2024 | 143 |
Journal Rank
Year | Value |
---|---|
2024 | 1896 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 2170 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine and Pharmacology, Toxicology and Pharmaceutics, designed to support cutting-edge academic discovery.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Citation: 1603
Authors: Roland R, Matthew W, Michael A, Annie, William A, Brian D, Mary P, Margaret A
-
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
Citation: 1266
Authors: Stephen, Anthony, Jeffrey, Gabrielle, Tara, Barry, Sarah E, Alexander, Krystallia, James, Zhe, Patricia, Brian L
-
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Citation: 916
Authors: Michael P, Alyssa A, Jessica A, Claire E, PCR, Rick J
-
Pilot study of the 5-HT<sub>2A</sub>R agonist psilocybin in the treatment of tobacco addiction
Citation: 749
Authors: Matthew W, Albert, Mary P, Roland R
-
Review: Suicide and schizophrenia: a systematic review of rates and risk factors
Citation: 668
Authors: Kahyee, Mark
-
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology
Citation: 648
Authors: GM, PM, IN, JK, TRH, A, DR, S, JR, H, EA, O, S, N, I, IC, H, DR, R, M, C, BJ, KEA, JMA, D, E, AH
-
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
Citation: 637
Authors: RR, WA, MW, UD, R.
-
Glutamate and dopamine in schizophrenia: An update for the 21<sup>st</sup>century
Citation: 614
Authors: Oliver, Rob, James